General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Seaport Therapeutics ×
Seaport Therapeutics is a clinical-stage biopharmaceutical company focused on the development of neuropsychiatric medicines in areas of unmet patient needs.